(Q36042989)

11 August 2017

ICRF-159 enhancement of radiation response in combined modality therapies. II. Differential responses of tumour and normal tissues (English)

1 reference

https://api.crossref.org/works/10.1038/BJC.1979.96

11 August 2017

1 reference

7 June 2023

author name string

C. J. Kovacs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486308

5 July 2022

M. J. Evans

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486308

5 July 2022

D. R. Burholt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486308

5 July 2022

L. L. Schenken

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486308

5 July 2022

language of work or name

English

0 references

publication date

1 May 1979

1 reference

PMC publication ID

2009893

full work available at URL

11 August 2017

https://europepmc.org/articles/PMC2009893

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486308

https://europepmc.org/articles/PMC2009893?pdf=render

5 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486308

http://www.nature.com/articles/bjc197996.pdf

5 July 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.1979.96

http://www.nature.com/articles/bjc197996

7 June 2023

1 reference

https://api.crossref.org/works/10.1038/BJC.1979.96

British Journal of Cancer

7 June 2023

published in

1 reference

11 August 2017

39

1 reference

11 August 2017

5

1 reference

11 August 2017

524-530

1 reference

Mechanism of intestinal radiosensitization by actinomycin D

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009893

ICRF-159 enhancement of radiation response in combined modality therapies. I. Time/dose relationships for tumour response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009893

Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour line

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009893

Proliferative character and growth modes of neoplastic disease as determinants of chemotherapeutic efficacy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009893

Interaction of ICRF 159 with radiation, and its effect on sub-lethal and potentially lethal radiation damage in vitro

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009893

Phase I study of ICRF-159 (NSC-129943) in human solid tumors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009893

Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009893

Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors

23 September 2018

1 reference

12 December 2020

Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159

1 reference

12 December 2020

Cumulative Cytostatic Effect of ICRF 159

1 reference

12 December 2020

Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159

1 reference

12 December 2020

Blood clearance of ICRF 159 (NSC-129943)

1 reference

12 December 2020

Intestinal Crypt Survival and Total and Per Crypt Levels of Proliferative Cellularity Following Irradiation: Single X-Ray Exposures

1 reference

12 December 2020

Mode of Action of the Cytostatic Agent ‘ICRF 159’

1 reference

12 December 2020

Effects of single-dose, whole-body, 60Co gamma irradiation on number of cells in DNA synthesis and mitosis in the mouse duodenal epithelium

1 reference

12 December 2020

Biochemical studies on growth-inhibitory bisdioxopiperazines. I. Effect on dna, rna and protein synthesis in mouse-embryo fibroblasts

1 reference

12 December 2020

Effect of ICRF159 on the mammalian cell cycle: significance for its use in cancer chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1979.96

1 reference

11 August 2017

1 reference

PMC publication ID

2009893

11 August 2017

1 reference

PMC publication ID

2009893